Oxford Maternal & Perinatal Health Institute (OMPHI)
The Oxford Maternal & Perinatal Health Institute (OMPHI) works alongside Nuffield Department of Women's & Reproductive Health - bringing together world experts to resolve priority maternal and perinatal health problems on a global scale.
ABOUT US
The Oxford Maternal & Perinatal Health Institute was founded in 2009 under the aegis of Green Templeton College, University of Oxford. We engage medical researchers, social scientists and health management experts in some of the major issues affecting the health of mothers and newborn babies, particularly in resource-poor settings. We are running 4 large, global studies involving over 350 researchers from a wide range of countries.
OUR PROJECTS
|
INTERGROWTH-21st PROJECT
See INTERGROWTH -21st overview and collaborators here |
|
INTERBIO-21st STUDY
See INTERBIO-21st overview and collaborators here |
|
INTERPRACTICE-21st PROJECT
See INTERPRACTICE-21st overview and collaborators here |
|
INTERCOVID
See INTERCOVID overview and collaborators here |
OMPHI FELLOWSHIP
The OMPHI International fellowship is awarded to fellows to develop specific skills relevant to the field of global Maternal & Perinatal Health.
See Current Fellows and Past Fellows
our funders
Our research focuses on fetal growth and nutrition and the effects of infection (e.g.malaria) in pregnancy; initiatives aimed at developing e-learning programmes in developing countries, and surveys of healthcare providers in resource-poor settings to identify barriers to implementing effective interventions in pregnancy. Our studies are funded by:
Bill & Melinda Gates Foundation
Family Larsson-Rosenquist Foundation
OUR PARTNERS
MHTF is a project of the Women and Health Initiative at the Harvard T.H.Chan School of Public Health which works to create a strong, well-informed and integrated community with equitable access to high-quality technical evidence to eliminate preventable maternal mortality and morbidity worldwide. MHTF is led by Ana Langer, a physician specializing in pediatrics and neonatology and a reproductive health expert.
OMPHI also works with The Geneva Foundation for Medical Education and Research on various joint initiatives. GFMER is a non-profit organisation established in 2002. It is supported by the Republic and Canton of Geneva, the Department of Social Affairs of the City of Geneva and other Swiss and international institutions. The Foundation works in close collaboration with the World Health Organization (WHO). GFMER is a WHO Collaborating Centre in Education and Research in Human Reproduction. The overall objectives of the Foundation are to furnish health education and research programmes that can be applied by developing countries, and countries in economic transition, and to establish collaboration between entities from the public and private sectors. See more
Family Larsson-Rosenquist Foundation is an independent, charitable organisation founded in an effort to fulfil the family’s vision of a world in which every child is granted an optimum start in life through the benefits of breast milk.
Our team
-
Michael Katz
President of Oxford Maternal and Perinatal Health Institute (OMPHI).
-
Stephen Kennedy
Professor of Reproductive Medicine and Director of the Oxford Maternal and Perinatal Health Institute (OMPHI).
-
Aris Papageorghiou
Professor of Fetal Medicine and Director of Research of the Oxford Maternal and Perinatal Health Institute (OMPHI).
-
Jimena Villar de Onis
Deputy Director for Programmes of the Oxford Maternal and Perinatal Health Institute (OMPHI).
Latest Publications
- COVID-19 Vaccination for Pregnant People to Prevent Serious Illness, Deaths, and Adverse Pregnancy Outcomes from COVID-19 Download it here
- This INTERCOVID paper is being cited in The Centers for Disease Control and Prevention Advisory
- "Maternal and Neonatal Morbidity and Mortality Among Pregnant Women With and Without COVID-19 Infection: The INTERCOVID Multinational Cohort Study" Download it here
- "Association Between Preterm Birth Phenotypes and Differential Morbidity, Growth and Neurodevelopment at Age 2 years". Download it here
Latest News
The results from the INTERCOVID study showing the risk of COVID-19 during pregnancy have been used by Ministry of Health in Argentina to underpin their recommendation that pregnant women should be prioritised for vaccination.
20,000 clinicians in China learn about INTERGROWTH-21st fetal growth standards during a Zoom lecture by the Birth Defects Prevention and Intervention Expert Committee of Chinese Preventive Medical Association.
OMPHI Fellow Dr Michelle Fernandes (pictured) has been awarded an MRC postdoctoral Clinical Research Training Fellowship at the MRC Lifecourse Epidemiology Unit at the University of Southampton. Her project will build significantly on her work with INTERGROWTH and INTERBIO, and represents an extension of this to the development of a clinically relevant tool to predict, at birth and at 1 year, the risk for neurodevelopment delay at 2 years measured on the INTER-NDA. The meta dataset will bring together data from over 8000 children 13 countries in which the INTER-NDA has been used in 9 cohorts.
A study of more than 2,100 pregnant women across 18 countries worldwide has revealed that COVID-19 is associated with a higher risk of severe maternal and newborn complications than previously recognised. The paper, Maternal and Neonatal Morbidity and Mortality Among Pregnant Women With and Without COVID-19 Infection: The INTERCOVID Multinational Cohort Study has received lots of press coverage including the Telegraph, BBC Women's Hour, CNN and Reuters. Read more
